{"title":"妊娠期甲状腺激素参考范围:印度孕妇需要定制","authors":"Nalini Arora, Pallavi Kashyap, Dipankar Saren, Priyanka Meel, Joya Ghosh, Ashish Yadav","doi":"10.1007/s13224-025-02117-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The precise interpretation of thyroid function tests during pregnancy needs population-based trimester-specific data among pregnant women. This study was to determine trimester-specific reference range for free triiodothyronine (FT3), free thyroxine (FT4) and thyrotropin (TSH) among pregnant women in India.</p><p><strong>Methods: </strong>In this prospective observational study, asymptomatic pregnant women with single fetus were enrolled from each trimester. Serum FT3, FT4, TSH and anti-thyroperoxidase (anti-TPO) antibodies were estimated using electrochemiluminescence technique.</p><p><strong>Results: </strong>Among 918 pregnant women, 82 women were excluded due to the presence of anti-TPO antibodies (76) and overt hypothyroidism (6). Among the remaining 836 women, 279 (33.3%) were in first trimester, 309 (36.9%) in second and 248 (29.6%) in third trimester. The 5th and 95th percentile values for each trimester were used as reference ranges. For all three hormones, the reference ranges for the first, second and third trimesters were: FT3 (1.59-3.64, 1.60-3.50 and 1.44-3.28 pg/dl), FT4 (0.64-1.12, 0.64-1.05 and 0.60-1.01 ng/dl) and TSH (0.21-4.95, 0.23-4.90 and 0.14-4.59 µIU/ml). The mean and median values for TSH between each trimester showed no statistically significant difference. No specific trend was seen for FT3 and TSH with advancing gestation. FT4 showed a decreasing trend with advancing trimester (P value: first versus second = 0.01, first versus third = 0.00003 and second versus third = 0.004). The reference range (<i>N</i> = 836) irrespective of trimester for thyroid hormones was: FT3 (1.53-3.46 pg/dl), FT4 (0.63-1.08 ng/dl) and TSH (0.19-4.72 µIU/ml).</p><p><strong>Conclusion: </strong>The trimester-specific reference levels of TSH among pregnant women from India are significantly higher than 4 mIU/L (American Thyroid Association 2017).</p>","PeriodicalId":51563,"journal":{"name":"Journal of Obstetrics and Gynecology of India","volume":"75 3","pages":"246-252"},"PeriodicalIF":0.6000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12204971/pdf/","citationCount":"0","resultStr":"{\"title\":\"Reference Range of Thyroid Hormones in Pregnancy: Customization Needed for Pregnant Women in India.\",\"authors\":\"Nalini Arora, Pallavi Kashyap, Dipankar Saren, Priyanka Meel, Joya Ghosh, Ashish Yadav\",\"doi\":\"10.1007/s13224-025-02117-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The precise interpretation of thyroid function tests during pregnancy needs population-based trimester-specific data among pregnant women. This study was to determine trimester-specific reference range for free triiodothyronine (FT3), free thyroxine (FT4) and thyrotropin (TSH) among pregnant women in India.</p><p><strong>Methods: </strong>In this prospective observational study, asymptomatic pregnant women with single fetus were enrolled from each trimester. Serum FT3, FT4, TSH and anti-thyroperoxidase (anti-TPO) antibodies were estimated using electrochemiluminescence technique.</p><p><strong>Results: </strong>Among 918 pregnant women, 82 women were excluded due to the presence of anti-TPO antibodies (76) and overt hypothyroidism (6). Among the remaining 836 women, 279 (33.3%) were in first trimester, 309 (36.9%) in second and 248 (29.6%) in third trimester. The 5th and 95th percentile values for each trimester were used as reference ranges. For all three hormones, the reference ranges for the first, second and third trimesters were: FT3 (1.59-3.64, 1.60-3.50 and 1.44-3.28 pg/dl), FT4 (0.64-1.12, 0.64-1.05 and 0.60-1.01 ng/dl) and TSH (0.21-4.95, 0.23-4.90 and 0.14-4.59 µIU/ml). The mean and median values for TSH between each trimester showed no statistically significant difference. No specific trend was seen for FT3 and TSH with advancing gestation. FT4 showed a decreasing trend with advancing trimester (P value: first versus second = 0.01, first versus third = 0.00003 and second versus third = 0.004). The reference range (<i>N</i> = 836) irrespective of trimester for thyroid hormones was: FT3 (1.53-3.46 pg/dl), FT4 (0.63-1.08 ng/dl) and TSH (0.19-4.72 µIU/ml).</p><p><strong>Conclusion: </strong>The trimester-specific reference levels of TSH among pregnant women from India are significantly higher than 4 mIU/L (American Thyroid Association 2017).</p>\",\"PeriodicalId\":51563,\"journal\":{\"name\":\"Journal of Obstetrics and Gynecology of India\",\"volume\":\"75 3\",\"pages\":\"246-252\"},\"PeriodicalIF\":0.6000,\"publicationDate\":\"2025-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12204971/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Obstetrics and Gynecology of India\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s13224-025-02117-5\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/5/13 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Obstetrics and Gynecology of India","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s13224-025-02117-5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/13 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
Reference Range of Thyroid Hormones in Pregnancy: Customization Needed for Pregnant Women in India.
Background: The precise interpretation of thyroid function tests during pregnancy needs population-based trimester-specific data among pregnant women. This study was to determine trimester-specific reference range for free triiodothyronine (FT3), free thyroxine (FT4) and thyrotropin (TSH) among pregnant women in India.
Methods: In this prospective observational study, asymptomatic pregnant women with single fetus were enrolled from each trimester. Serum FT3, FT4, TSH and anti-thyroperoxidase (anti-TPO) antibodies were estimated using electrochemiluminescence technique.
Results: Among 918 pregnant women, 82 women were excluded due to the presence of anti-TPO antibodies (76) and overt hypothyroidism (6). Among the remaining 836 women, 279 (33.3%) were in first trimester, 309 (36.9%) in second and 248 (29.6%) in third trimester. The 5th and 95th percentile values for each trimester were used as reference ranges. For all three hormones, the reference ranges for the first, second and third trimesters were: FT3 (1.59-3.64, 1.60-3.50 and 1.44-3.28 pg/dl), FT4 (0.64-1.12, 0.64-1.05 and 0.60-1.01 ng/dl) and TSH (0.21-4.95, 0.23-4.90 and 0.14-4.59 µIU/ml). The mean and median values for TSH between each trimester showed no statistically significant difference. No specific trend was seen for FT3 and TSH with advancing gestation. FT4 showed a decreasing trend with advancing trimester (P value: first versus second = 0.01, first versus third = 0.00003 and second versus third = 0.004). The reference range (N = 836) irrespective of trimester for thyroid hormones was: FT3 (1.53-3.46 pg/dl), FT4 (0.63-1.08 ng/dl) and TSH (0.19-4.72 µIU/ml).
Conclusion: The trimester-specific reference levels of TSH among pregnant women from India are significantly higher than 4 mIU/L (American Thyroid Association 2017).
期刊介绍:
Journal of Obstetrics and Gynecology of India (JOGI) is the official journal of the Federation of Obstetrics and Gynecology Societies of India (FOGSI). This is a peer- reviewed journal and features articles pertaining to the field of obstetrics and gynecology. The Journal is published six times a year on a bimonthly basis. Articles contributed by clinicians involved in patient care and research, and basic science researchers are considered. It publishes clinical and basic research of all aspects of obstetrics and gynecology, community obstetrics and family welfare and subspecialty subjects including gynecological endoscopy, infertility, oncology and ultrasonography, provided they have scientific merit and represent an important advance in knowledge. The journal believes in diversity and welcomes and encourages relevant contributions from world over. The types of articles published are: · Original Article· Case Report · Instrumentation and Techniques · Short Commentary · Correspondence (Letter to the Editor) · Pictorial Essay